How to Approach the Patient With BRAF Mutant Tumor
Earn CME for related activities: https://www.naccme.com/oln
In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Scott Kopetz discusses best practices for the treatment of BRAF-mutant colorectal cancer.
© 2019 Imedex, an HMP Company
Видео How to Approach the Patient With BRAF Mutant Tumor канала ImedexCME
In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Scott Kopetz discusses best practices for the treatment of BRAF-mutant colorectal cancer.
© 2019 Imedex, an HMP Company
Видео How to Approach the Patient With BRAF Mutant Tumor канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
What is the optimal therapy for BRAF mutant metastatic colorectal cancer?
ESMO 2020 Satellite Symposium: Philip Jermann - NTRK, RET and other fusion biomarkers testing
BRAF mutation – What does it mean? What are the complications of BRAF Inhibitors?
bcr-abl Translocation Mechanism | Philadelphia Chromosome
Introduction to Immunotherapy (Immunotherapy Documentary Part I)
How Molecular Testing is Used in the Treatment of Brain Tumors | Dana-Farber Cancer Institute
What the D Dimer test tells you.
An Approach to Diagnosis and Staging of MDS: From Morphology to Genetics
Colorectal cancer: Mayo Clinic Radio
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
BRAF/MEK Inhibitors in Metastatic Melanoma
Vitamin D: It's Not Just For Bones Anymore
What Can You Actually Learn from Your Genome?
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz
Topical challenges in the management of ET
Understanding the mutations behind colorectal cancer | Dr Kate Marks
Update: Left versus right sided colon cancers: Biomarkers versus biology
Understanding non-response and loss of response in IBD: Which is it and when do we change classes?
Debate: Liquid biopsy will replace tissue biopsy? - Yes
BRAF Mutations in Colorectal Cancer